Pfizer, BioNTech hit pause on COVID shot trial as enrollment falls flat

Pfizer Inc PFE and its German COVID-19 vaccine partner BioNTech SE BNTX have reportedly halted recruitment for a large U.S.
Devdiscourse

Pfizer and BioNTech Pause COVID-19 Vaccine Trial Due to Low Enrollment

Pfizer and BioNTech have stopped their large U.S. COVID-19 vaccine trial in adults aged 50 to 64, citing insufficient ...
Time

The FDA Authorized a Booster Shot of the Pfizer-BioNTech COVID-19 Vaccine—But Not For Everyone

The U.S. Food and Drug Administration (FDA) on Sept. 22 authorized booster doses for certain people already vaccinated against COVID-19 but at high risk of infection, including those over age 65 and ...
ksby

FDA authorizes COVID-19 booster shots for millions of Americans

Millions of Americans are one step closer to getting a COVID-19 booster shot. The Food and Drug Administration (FDA) amended its emergency use authorization for a Pfizer booster shot Wednesday. It ...

Exclusive - Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
AOL

FDA authorizes Pfizer booster shots for children ages 5 to 11

The Food and Drug Administration has approved a booster dose of Pfizer/BioNTech’s COVID-19 vaccine for children ages 5 to 11. Drug-maker Pfizer provided company data last month indicating a third dose ...